The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round. Generate Biomedicines is touting […]
Biotechnology
Trending topics and news from the Biotechnology category
Back to news homeKiwi Bio aims to free irritable bowel syndrome sufferers from restrictive diets
One in 20 people suffer from irritable bowel syndrome, a common disorder related to how your bowels work, that can cause a number of symptoms, including abdominal pain and difficulty […]
In an increasingly hot biotech market, protecting IP is key
John Flavin Contributor More posts by this contributor 2021 should be a banner year for biotech startups that make smart choices early Kevin O’Connor Contributor Kevin A. O’Connor, Ph.D., is […]
Cutting out carbon emitters with bioengineering at XTC Global Finals on July 22
Bioengineering may soon provide compelling, low-carbon alternatives in industries where even the best methods produce significant emissions. Utilizing natural and engineered biological process has led to low-carbon textiles from Algiknit, […]
Extra Crunch roundup: Video pitch decks, Didi’s regulatory struggles, Nothing CEO interview
The numbers don’t lie. According to DocSend, the average pitch deck is reviewed for just three minutes. And if you think a senior VC is studying the presentation your team […]
Bluu Biosciences raises cash to become Europe’s first purveyor of lab grown salmon, trout, and carp
A startup from Europe is joining the race to become the first big provider of lab grown fish. Bluu Biosciences has raised €7 million in a round of financing from […]
Foresite Capital raises $969 million fund to invest in healthcare startups across all stages of growth
Health and life science specialist investment firm Foresite Capital has raised a new fund, its fifth to date, totally $969 million in commitments from LPs. This is the firm’s largest […]
Immunai raises $60M as it expands from improving immune therapies to discovering new ones, too
Just three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. Despite its youth, Immunai has […]